MOREPEN LABORATORIES
Back to Income Statement
|
MOREPEN LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹118 Cr | ₹96 Cr | ₹39 Cr | ₹102 Cr | ₹97 Cr |
What is the latest Consolidated Net Profit of MOREPEN LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹118 Cr |
| Mar2024 | ₹96 Cr |
| Mar2023 | ₹39 Cr |
| Mar2022 | ₹102 Cr |
| Mar2021 | ₹97 Cr |
How is Consolidated Net Profit of MOREPEN LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹118 Cr | 22.73 | |
| Mar2024 | ₹96 Cr | 148.64 | |
| Mar2023 | ₹39 Cr | -61.97 | |
| Mar2022 | ₹102 Cr | 4.73 | |
| Mar2021 | ₹97 Cr | - | |
Compare Consolidated Net Profit of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹3,230.5 Cr | -0.6% | 16.3% | -3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.8% | 8.3% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 7.1% | 9% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | 2% | 12.1% | 49.6% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.7% | 4.1% | -3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.7% | -4.2% | -3.1% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | -0.6% |
16.3% |
-3% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses